ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure with ...

Panelists discuss how effective heart failure management requires collaborative care across multiple specialties (primary care, cardiology, endocrinology, nephrology) with advanced practice providers ...

A low dose of digoxin may help people with heart failure avoid hospitalization and reduce the risk of death, according to ...

Adults who have heart failure with a left ventricular ejection fraction of 40% or more face a high risk of hospitalization for heart failure and cardiovascular death. People who have heart failure ...

When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying ...

A centuries-old heart medicine is making a comeback. New research led by cardiologists at University Medical Center Groningen ...

American Heart Association announced UT Health Tyler received the Get With The Guidelines (GWTG) – Heart Failure Gold Plus ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

A low-cost heart drug is back in the spotlight after researchers linked it to 25% fewer hospital admissions.

A centuries-old heart drug costing less than ten cents a day could help keep heart-failure patients out of the hospital. New ...